Company Description
Charming Medical Limited, through its subsidiaries, engage in the provision of beauty, wellness, and postpartum services under the Beauty Lab brand name in Hong Kong.
Its services includes womb-warming therapy, BTS (Beauty, Tailor-made, Slim) pelvic detox therapy, agarwood moxibustion therapy, traditional Chinese medicine (TCM)-inspired prenatal massage, and Indonesian traditional abdominal binding.
The company also provides TCM-inspired supplements products, which includes Beauty Lab home herbal uterine care patch, probiotic intimate wash, and Yin nourishing pill sets; and beauty products, including ginseng soothing anti-allergy moisturizing wash for skin issues, and scalp health.
In addition, it offers consultancy services to provide TCM-inspired therapy technical training and dietary therapy training to other well-established and reputable beauty salons, massage centers, and similar institutions.
Further, the company’s products are used for the treatment of alleviating premenstrual syndrome, menstrual irregularities, dysmenorrhea, leukorrhea, pelvic inflammatory disease, menopausal care, breast health, uterine health, enhance physical weakness, balance endocrine functions, and other common women’s health issues.
it operates wellness centres. The company was founded in 2016 and is headquartered in Causeway Bay, Hong Kong.
| Country | Hong Kong |
| Founded | 2016 |
| IPO Date | Oct 21, 2025 |
| Industry | Medical Care Facilities |
| Sector | Healthcare |
| Employees | 49 |
| CEO | Kit Wong |
Contact Details
Address: Hang Lung Centre, Units 1803-1806, 18/F Causeway Bay Hong Kong | |
| Phone | 852 2116 1492 |
Stock Details
| Ticker Symbol | MCTA |
| Exchange | NASDAQ |
| Share Class | Class A Shares |
| Fiscal Year | April - March |
| Reporting Currency | USD |
| IPO Price | $4.00 |
| CIK Code | 2035992 |
| CUSIP Number | G20528108 |
| ISIN Number | VGG205281089 |
| SIC Code | 8090 |
Key Executives
| Name | Position |
|---|---|
| Kit Wong | Chief Executive Officer, Director, and Chairman of the Board |
| Ching Man Cheung | Chief Financial Officer |
| Josephine Yan Yeung | Independent director nominee |
| Leut Ming Gung | Independent director nominee |
| Shu Tai Victor Yu | Independent director nominee |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 28, 2025 | 6-K | Report of foreign issuer |
| Nov 13, 2025 | 6-K | Report of foreign issuer |
| Oct 28, 2025 | 6-K | Report of foreign issuer |
| Oct 22, 2025 | 6-K | Report of foreign issuer |
| Oct 21, 2025 | 424B4 | Prospectus |
| Oct 20, 2025 | CERT | Certification by an exchange approving securities for listing |
| Oct 20, 2025 | 8-A12B | Registration of securities |
| Sep 30, 2025 | EFFECT | Notice of Effectiveness |
| Sep 10, 2025 | F-1/A | [Amend] Registration statement for certain foreign private issuers |
| Aug 7, 2025 | FWP | Free Writing Prospectus |